Figure 1
Flowchart of the included studies in systematic review.
Table 1
Basic information of included studies.
| Author, year | Time period | Country | Survival rate (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 7 | 10 | |||
| Al-Idrissi, 1992 | 1981–1981 | Saudi Arabia | 62 | ||||||
| Ibrahim, 1998 | 1985–1985 | Saudi Arabia | 55 | ||||||
| Fakhro, 1999 | 1982–1982 | Bahrain | 68.8 | 57.3 | 39.31 | ||||
| Ahmed, 2002 | 1990–1990 | Tunisia | 50.5 | 50 | |||||
| Al Moundhri, 2004 | 1996–1996 | Oman | 67 | ||||||
| Motawy, 2004 | 1993–1993 | Kuwait | 76 | ||||||
| Vahdaninia, 2004 | 1997 | Iran | 62 | ||||||
| Ghavam-Nasiri, 2005 | 1995–1995 | Iran | 80.4 | 47.7 | |||||
| Ibrahim, 2005 | 1992–1992 | Saudi Arabia | 74 | ||||||
| Ravichandran, 2005 | 1994–1994 | Saudi Arabia | 93.9 | 79.2 | 59.6 | ||||
| Babaei, 2005 | 1991–1991 | Iran | 94 | 89 | 84 | 76 | 61 | ||
| Rajaeifard, 2005 | 1993–1993 | Iran | 97 | 82 | 70 | 53 | |||
| Mousavi, 2006 | 1998–1998 | Iran | 75 | ||||||
| Akbari, 2006 | 1996–1996 | Iran | 76.6 | ||||||
| Khanfir, 2006 | 1995–1995 | Tunisia | 57 | ||||||
| Yaghmaei, 2008 | 1991–1991 | Iran | 86.9 | 62 | 58 | 47 | |||
| Heydari, 2009 | 2001–2001 | Iran | 97 | 67 | 45 | ||||
| Rezaianzadeh, 2009 | 2001–2001 | Iran | 76 | 58 | |||||
| Sadjadi, 2009 | 2003–2003 | Iran | 92 | ||||||
| Abahssain, 2010 | 2003–2003 | Morocco | 80.6 | ||||||
| Arkoob, 2010 | 1997–1997 | Jordan | 91.6 | 80.1 | 70.2 | 65.8 | 59.3 | ||
| El Mongy, 2010 | 1999–1999 | Egypt | 96.4 | 91.4 | |||||
| Al-Moundhri, 2011 | 2003–2003 | Oman | 78 | ||||||
| Fouladi, 2011 | 2003–2003 | Iran | 51 | ||||||
| Hamdan, 2011 | 1994–1994 | Saudi Arabia | 96.3 | 82.7 | 65.3 | ||||
| Tarawneh, 2011 | 1997–1997 | Jordan | 93.1 | 82.7 | 74.33 | 68.7 | 64.2 | ||
| Movahedi, 2012 | 2001–2001 | Iran | 72 | ||||||
| Rahmani, 2012 | 2009–2009 | Iran | 97.3 | 87.02 | 75.72 | ||||
| Rais, 2012 | 2007–2007 | Morocco | 76.5 | ||||||
| Vostakolaei, 2012 | 1999–1999 | Iran | 72 | ||||||
| Ziaei, 2013 | 1997–1997 | Iran | 96 | 86 | 81 | 79 | 76 | ||
| Haghighat, 2013 | 1997–1997 | Iran | 96 | 87 | |||||
| Fallahzadeh, 2014 | 2002–2002 | Iran | 95 | 86 | 82 | 76 | 70 | ||
| Fayaz, 2014 | 1999–1999 | Kuwait | 83.2 | 81.5 | |||||
| Sedehi, 2014 | 2003–2003 | Iran | 83 | 71 | 67 | 59 | 51 | ||
| Fazeli, 2014 | 2007–2007 | Iran | 98 | 96 | 92 | 89 | 87 | ||
| Hamadeh, 2014 | 2000–2000 | Bahrain | 84 | 63 | 49 | ||||
| Faradmal, 2014 | 2004–2004 | Iran | 68 | ||||||
| Karimi, 2014 | 2006–2006 | Iran | 75 | ||||||
| Baghestani, 2015 | 1998–1998 | Iran | 93 | 75 | 52 | ||||
| El Mistiri, 2015 | 2003–2003 | Libya | 60.6 | ||||||
| Jamshed, 2015 | 1995–1995 | Pakistan | 70 | 54 | |||||
| Mahmood, 2015 | 2000–2000 | Pakistan | 74.9 | ||||||
| Rampisheh, 2015 | 2001–2001 | Iran | 95 | 88 | 78 | 73 | 68 | ||
| Payandeh, 2015 | 2001–2001 | Iran | 82 | 72 | 64 | ||||
| Rejali, 2015 | 1994–1994 | Iran | 71.2 | ||||||
| Derkaoui, 2016 | 2010–2010 | Morocco | 71.4 | ||||||
| Faradmal, 2016 | 2000–2000 | Iran | 90 | 73 | 62.5 | ||||
| Kumar, 2016 | 1999–1999 | Pakistan | 75 | ||||||
| Mechita, 2016 | 2005–2005 | Morocco | 97.1 | 89.2 | 80.6 | ||||
| Rahimzadeh, 2016 | – | Iran | 95.6 | 80.8 | 69.5 | 58.1 | |||
| YektaKooshali, 2016 | – | Iran | 68.84 | ||||||
| Bakhshi, 2017 | 2010–2010 | Iran | 92 | ||||||
| Davoudi Monfared, 2017 | 2006–2006 | Iran | 87.8 | ||||||
| El Amine Elhadj, 2017 | 2004–2004 | Tunisia | 49.1 | 33.7 | |||||
| Hosseinpour Feizi, 2017 | 2007–2007 | Iran | 98 | 88 | 82 | ||||
| Najafi, 2017 | 2007–2007 | Iran | 96 | 88.1 | |||||
Figure 2
Forest plot of one-year survival rate of breast cancer in EMRO countries.
Figure 3
Forest plot of two-year survival rate of breast cancer in EMRO countries.
Figure 4
Forest plot of three-year survival rate of breast cancer in EMRO countries.
Figure 5
Forest plot of four-year survival rate of breast cancer in EMRO countries.
Figure 6
Forest plot of five-year survival rate of breast cancer in EMRO countries.
Figure 7
Forest plot of ten-year survival rate of breast cancer in EMRO countries.
Table 2
Result of meta-analysis of survival rate of breast cancer in EMRO base on each country and year of survival.
| Country | Survival rate by year | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 7 | 10 | |
| Bahrain | 84 (81.7–86.2) | NR | NR | NR | 64.5 (59.5–69.5) | 57.3 (48.5–66.1) | 45 (35.7–54.3) |
| Egypt | NR | NR | 96.4 (95.2–97.5) | NR | 91.4 (89.6–93.1) | NR | NR |
| Iran | 94 (92.4–95.6) | 88 (81.4–94.6) | 80.8 (77.5–84.1) | 74.8 (64.4–85) | 69 (64.5–73.4) | 79 (74.1–83.8) | 59.2 (49–69.4) |
| Jordan | 92.5 (91.1–93.9) | 81.6 (79.1–84.1) | 72.4 (68.4–76.4) | 67.5 (64.7–80.2) | 61.9 (57.1–66.7) | NR | NR |
| Kuwait | NR | NR | 83.2 (79.3–87) | NR | 78.3 (73–83.7) | NR | NR |
| Libya | NR | NR | NR | NR | 60.6 (53.2–68) | NR | NR |
| Morocco | 97.1 (95.7–98.4) | NR | 85 (76.6–93.4) | NR | 78.4 (74.2–82.7) | NR | NR |
| Oman | NR | NR | NR | NR | 72.5 (61.7–83.2) | NR | NR |
| Pakistan | NR | NR | NR | NR | 73.2 (69.7–76.7) | NR | 54 (51.2–56.8) |
| Saudi Arabia | NR | NR | NR | NR | 65.3 (58.4–72.1) | NR | 55 (49.5–60.5) |
| Tunisia | NR | 49.1 (31.1–67.1) | 33.7 (19.3–51.2) | NR | 51.5 (46.8–56.1) | 50 (46.4–53.6) | NR |
| Overall | 93.6 (92.3–95) | 85 (79.9–90) | 79.8 (76–83.7) | 72.6 (65–80.2) | 69.2 (66.5–72) | 62.1 (41.8–82.3) | 55.5 (49.3–61.8) |
Figure 8
The five-year survival rate of breast cancer in EMRO countries.
Figure 9
Result of meta-regression for five-year survival rate based on year of study.
Figure 10
Funnel plot of standard error by point estimate for assessment of publication bias.